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Abstract: Repair of DNA double-strand breaks via homologous recombination can produce double Hol-
liday junctions (dHJs) that require enzymatic separation. Topoisomerase III￿ (TopIII￿) together with
RMI1 disentangles the final hemicatenane intermediate obtained once dHJs have converged. How bind-
ing of RMI1 to TopIII￿ influences it to behave as a hemicatenane dissolvase, rather than as an enzyme
that relaxes DNA topology, is unknown. Here, we present the crystal structure of human TopIII￿ com-
plexed to the first oligonucleotide-binding domain (OB fold) of RMI1. TopIII assumes a toroidal type
1A topoisomerase fold. RMI1 attaches to the edge of the gate in TopIII￿ through which DNA passes.
RMI1 projects a 23-residue loop into the TopIII￿ gate, thereby influencing the dynamics of its opening
and closing. Our results provide a mechanistic rationale for how RMI1 stabilizes TopIII￿-gate opening to
enable dissolution and illustrate how binding partners modulate topoisomerase function.
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Abstract:	  
DNA	   double-­‐strand	   breakage	   repair	   through	   homologous	   recombination	   produces	   double	   Holliday	  
junctions	   (dHJ).	   The	  entangled	  DNA	  duplexes	   comprising	   the	  dHJ	   require	  enzymatic	   separation.	  While	  
human	  topoisomerase	  TopIIIα	  serves	  in	  the	  final	  steps	  of	  dHJ	  decatenation,	  it	  requires	  assistance	  from	  
RMI1	   in	   vitro	   and	   in	   vivo.	   How	   RMI1	  modulates	   TopIIIα	   structure	   and	   function	   hence	   converting	   the	  
topoisomerase	  into	  a	  proficient	  decatenation	  enzyme	  remains	  unclear.	  Here	  we	  present	  the	  structure	  of	  
human	   TopIIIα	   complexed	   to	   the	   first	   oligonucleotide	   binding	   (OB-­‐fold)	   of	   RMI1	   at	   2.65	   Å.	   TopIIIα	  
assumes	  a	   canonical	   toroid	   topoisomerase	  1A	   fold,	  with	   the	  RMI1	  OB-­‐fold	  attached	   to	   the	   top	  of	   the	  
topoisomerase	   gate.	   RMI1	   injects	   a	   23-­‐residue	   loop	   into	   the	   central	   cavity	   of	   TopIIIα,	   which	   directly	  
influences	   the	   open/closure	   dynamics	   of	   the	   topoisomerase	   gate.	   We	   propose	   a	   decatenation	  
mechanism	   whereby	   epitopes	   stabilizing	   gate	   opening	   favor	   decatenation	   relative	   to	   relaxation,	  
demonstrating	  how	  topoisomerase	  function	  is	  modulated	  through	  its	  macromolecular	  environment.	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Introduction	  
Homologous	  recombination	  (HR)	  is	  a	  central	  pathway	  in	  the	  repair	  of	  double-­‐strand	  breaks	  and	  single-­‐
stranded	   gaps,	   and	   is	   required	   for	   maintaining	   and	   restarting	   stalled	   replication	   forks1,2.	   In	   HR,	   a	  
homologous	  DNA	  sequence	  templates	  the	  repair	  of	  the	  damaged	  DNA	  strand.	  Following	  DNA	  synthesis	  
and	  ligation,	  a	  double	  Holliday	  junction	  intermediate	  (dHJ)	   is	  produced,	  which	  interconnects	  two	  sister	  
chromatids3,4.	  These	  dHJ	  intermediates	  are	  processed,	  either	  in	  a	  crossover,	  or	  non-­‐crossover	  fashion5-­‐7.	  
Several	  nucleases	  are	  able	  to	  cleave	  the	  symmetrical	  Holliday	  junction,	  yielding	  an	  equal	  number	  of	  both	  
products.	  The	  mitotic	  crossovers	  products,	  however,	  carry	  the	  risk	  of	  loss	  heterozygosity	  (LOH),	  a	  known	  
driver	  of	  oncogenic	  transformation8,9.	  In	  mitotic	  cells	  LOH	  appears	  to	  be	  rare,	  contributing	  to	  only	  2.5%	  
of	  HR	  mediated	  double-­‐strand	  breakage	  repair	  events10.	  Alternative	  pathways	  hence	  exist	  in	  cells	  biasing	  
cellular	  HR	  completion	  towards	  non-­‐crossover	  completion.	  
The	  DNA	  molecules	  within	  the	  dHJ	  intermediate	  are	  topologically	  linked.	  The	  disjunction	  of	  the	  
entangled	   chromosomes	   can	   principally	   be	   accomplished	   through	   the	   duplex	   unwinding	   activity	   of	   a	  
specific	  RecQ-­‐type	  helicase,	  coupled	  to	  DNA	  strand	  unlinking	  by	  a	  type	  1A	  topoisomerase.	  The	  interplay	  
between	   RecQ	   helicase	   and	   topoisomerase,	   which	   is	   conserved	   in	   all	   kingdoms	   of	   life,	   exclusively	  
generates	  non-­‐crossover	  products11.	  In	  humans,	  TopIIIα	  works	  with	  BLM,	  a	  RecQ	  enzyme	  found	  mutated	  
in	  the	  cancer	  predisposing	  Bloom	  syndrome,	  while	  in	  yeast	  it	  is	  Sgs1	  that	  works	  in	  concert	  with	  Top312-­‐14.	  
Whilst	   Sgs1/BLM	  and	  Top3/TopIIIα	   are	   required	   to	  process	   various	   topologically	   linked	   substrates15,16,	  
they	   act	   in	   concert	   with	   an	   additional	   essential	   component:	   Rmi1,	   in	   yeast17,18,	   and	   the	   RMI1/RMI2	  
complex	  in	  human	  cells19,20.	  Together	  the	  RecQ	  helicase,	  Top3/IIIα	  and	  Rmi1/RMI1	  form	  the	  minimal	  dHJ	  
dissolvasome,	  loss	  or	  mutation	  of	  either	  component	  results	  in	  genomic	  instability	  in	  affected	  cells18,21,22.	  	  
dHJ	   dissolution	   requires	   a	   branch	   migration	   step	   that	   collapses	   the	   two	   HJs	   into	   a	   hemi-­‐
catenane,	   followed	   by	   a	   dissolution	   step	   that	   unhooks	   the	   hemi-­‐catenane	   intermediate	   into	   two	  
separate	   DNA	   duplexes.	   In	   yeast,	   where	   the	   reaction	   has	   been	   biochemically	   dissected	   in	   detail23-­‐25,	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convergence	  of	  the	  2	  HJs	   is	  driven	  by	  Sgs1	  in	  an	  ATP	  dependent	  process.	  Top3	  provides	  the	  enzymatic	  
unlinking	  activity	  for	  helicase	  mediated	  dHJ	  migration,	  and	  unhooks	  the	  final	  hemi-­‐catene23.	  	  
TopIIIα	   is	   a	  member	  of	   the	   toroidal	   type	  1A	   topoisomerases,	  which	   introduce	   single	   stranded	  
nicks	  in	  one	  strand	  (cut	  strand:	  C-­‐strand),	  allowing	  a	  second	  ssDNA	  strand	  to	  be	  transferred	  through	  the	  
nick	   (transfer	   strand:	   T-­‐strand).	  When	   T-­‐	   and	   C-­‐strands	   belong	   to	   separate	   duplexes,	   the	   outcome	   is	  
decatenation,	   should	   they	   both	   belong	   to	   the	   same	   plectonemicaly	   linked	   duplex	   then	   relaxation	   is	  
observed.	   The	   in/out-­‐movement	   of	   DNA	   single-­‐strand	   (T-­‐strand)	   is	   made	   possible	   by	   a	   gate	   of	  
intertwined	  β-­‐sheets	  allowing	  reversible	  opening/closure	  of	  the	  toroid26.	  In	  this	  context,	  the	  C-­‐strand	  is	  
cut	   in	   a	   reversible,	   ATP	   independent,	   trans-­‐esterification	   process	   giving	   rise	   to	   a	   5’-­‐tyrosine	   ssDNA	  
intermediate,	   with	   the	   T-­‐strand	   being	   moved	   through	   the	   nick27.	   Top3	   and	   TopIIIα,	   in	   isolation,	   are	  
relatively	   ineffective	   in	   relaxing	   negatively	   supercoiled	   plasmids,	   acting	   both	   as	   relatively	   poor	  
decatenases.	  Effective	  decatenation	  is	  bestowed	  in	  the	  presence	  of	  RMI1,	  however,	  which	  works	  while	  
inhibiting	  relaxase.	  In	  yeast,	  Rmi1	  has	  been	  shown	  biochemically	  to	  stabilize	  the	  open	  conformation	  of	  
the	  topoisomerase	  gate23.	  The	  molecular	  mechanism	  by	  which	  RMI1/Rmi1	  modulates	  TopIIIα/3	  function	  
bestowing	  decatenation	  properties	  that	  allow	  dHJ	  dissolution	  has	  remained	  elusive.	  	  
We	   have	   set	   out	   to	   define	   how	   RMI1/Rmi1	   modulates	   TopIIIα/3	   function	   converting	   the	  
complex	   into	   a	   single-­‐strand	   specific	   decatenase	   using	   structural,	   biochemical	   and	   cellular	   biological	  
approaches.	   We	   show	   in	   vitro	   and	   in	   vivo,	   that	   RMI1	   contributes	   to	   decatenation	   process	   through	  
donating	  of	  a	  decatenation	  loop	  in	  trans.	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Results	  	  
Construct	  design	  underlying	  structural	  studies	  of	  the	  TopIIIα–RMI1complex	  
Human	   TopIIIα	   and	   yeast	   Top3	   carry	   distinct	   sequence	   signatures	   that	   distinguish	   them	   from	   their	  
prokaryotic	  Top3	  counterparts	  (Supplementary	  fig.	  2,3	  for	  sequence	  alignment	  and	  conservation).	  In	  the	  
absence	  of	  structural	  information	  it	  is	  unclear	  to	  what	  extend	  the	  eukaryotic	  TopIIIα/Top3	  decatenases	  
diverge	   from	   their	   prokaryotic	   counterparts,	   and	   how	   RMI1	   complements	   topoisomerase	   function	  
conferring	  effective	  decatenase	  activity.	  	  
	   In	  an	  effort	  to	  address	  these	  questions	  we	  pursued	  the	  structure	  of	  the	  TopIIIα-­‐RMI1	  complex.	  
Complexes	   from	  S.	   cerevisiae,	  Xenopus	   laevis,	  Danio	   rerio,	  Mus	  musculus	   and	  Homo	   sapiens	  were	   co-­‐
expressed,	   purified	   and	   subjected	   to	   crystallization	   trials.	   Crystals	   were	   obtained	   after	   5-­‐6	   days	   for	  
human	  TopIIIα	  (residues	  1	  to	  753	  following	  deletion	  of	  residues	  753	  to	  1001)	  complexed	  to	  human	  RMI1	  
(DUF1767+OBN:	  residue	  1	  to	  219)	  (fig.	  1a,	  b,	  e),and	  belonged	  to	  space	  group	  P41212	  with	  one	  complex	  in	  
the	  asymmetric	  unit	   (Supplementary	   fig.	  5).	   The	   structure	  was	   solved	  by	  molecular	   replacement,	   and	  
refined	  to	  a	  maximal	  resolution	  of	  2.65Å	  (see	  methods).	  The	  domain	  boundaries	  for	  the	  human	  TopIIIα-­‐
RMI1	   (OBN)	   complex	   are	   equivalent	   to	   that	   of	   S.	   cerevisiae	   Top3-­‐RMI1.	   Human	   RMI1	   encompasses	   a	  
DUF1767	  three	  α-­‐helix	  bundle	  followed	  by	  an	  N-­‐	  (OBN)	  and	  C-­‐	  terminal	  (OBC)	  oligo-­‐nucleotide/saccharide	  
binding	  domain17,20	  (fig.	  1a,	  e).	  While	  absent	  in	  yeast,	  OBC	  is	  responsible	  for	  RMI2	  binding	  in	  the	  human	  
complex	  28,29.	  RMI2,	  in	  turn,	  recruits	  the	  dissolvasome	  to	  metazoan	  repair	  complexes	  such	  as	  the	  Fanconi	  
anemia	   complex30,31.	   Deletion	   of	   human	   RMI1-­‐OBC	   has	   no	   adverse	   effect	   on	   dHJ	   dissolution	   in	   vitro	  
making	  TopIIIα-­‐BLM-­‐RMI1	  (DUF1767+OBN)	  the	  minimal	  functional	  dissolvasome	  complex29.	  
Overview	  of	  the	  TopIIIα-­‐RMI1	  complex	  
The	  overall	   shape	  of	   the	   TopIIIα–RMI1	   complex	   resembles	   a	   brass	   doorknocker	   (fig.	   1b),	  with	   TopIIIα	  
forming	  the	  ring	  and	  RMI1	  acting	  as	  its	  base	  (fig	  1b).	  The	  biological	  unit	  was	  confirmed	  by	  single	  particle	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electron	   microscopy	   EM	   as	   well	   as	   mutation	   witin	   the	   heterodimer	   interface	   in	   the	   asymetric	   unit	  
(Supplementary	  fig.	  5	  and	  fig	  1b).	  
Human	  TopIIIα	  displays	  the	  canonical	  toroidal	  topoisomerase	  shape	  found	  in	  all	  type	  1A	  family	  
members	   solved	   to	   date	   (fig	   1b)	   32,33,34.	  Members	   of	   this	   family	   comprise	   five	   characteristic	   domains:	  
domain	  I,	  or	  toprim	  (topoisomerase-­‐primase),	  harbors	  an	  acidic	  cluster	  (residues	  D148,	  D150	  and	  E152)	  
binding	   the	   catalytic	   metal-­‐ion	   required	   for	   C-­‐strand	   cleavage26,35	   ;	   domain	   II	   provides	   the	   ~26	   Å	  
diameter	  topoisomerase	  gate	  formed	  by	  two	  antiparallel	  topo-­‐fold	  domains36;	  domains	  III	  and	  IV	  share	  
similar	  winged-­‐helix	   folds	   (also	   referred	   to	   as	   catabolite	   activator	   protein:	   CAP)37,38;	   domain	   III	   carries	  
the	   catalytic	   Tyrosine	   (Y362)	   needed	   for	   ssDNA	   cleavage	   and	   formation	   of	   the	   5’-­‐tyrosine	   ssDNA	  
intermediate27.	  The	  TopIIIα	  C-­‐terminal	  region	  (residues	  655	  to	  1001),	  also	  known	  as	  domain	  V,	  includes	  a	  
predicted	  Zinc	  finger	  motif	  (residues	  655	  to	  694).	  While	  domains	  I	  to	  IV	  are	  well	  defined	  in	  our	  structure,	  
density	   for	   domain	   V	   was	   not	   unambiguously	   buildable	   and	   has	   been	   omitted	   from	   the	   model.	   No	  
detectable	  Zn2+	  anomalous	  signal	  was	  observed	  that	  corresponds	  to	  domain	  V	  (data	  not	  shown).	  
We	  find	  that	  RMI1	  via	  its	  OBN	  β-­‐barrel	  domain	  attaches	  to	  the	  tip	  of	  the	  TopIIIα	  topoisomerase	  
gate	   (domain	   II)	   (fig	   1b).	   RMI1	   binds	   the	   toroidal	   TopIIIα	   diametric	   to	   the	   toprim	   ssDNA	  binding	   site,	  
with	   the	  RMI1	  N-­‐terminus	   projecting	   away	   from	   the	   topoisomerase.	   RMI1	   attaches	   to	   the	   top	   of	   the	  
topoisomerase	   gate,	   utilizing	   an	   interface	   frequently	   used	   by	   other	   OB-­‐fold	   containing	   proteins	   in	  
binding	   protein	   ligands,	   sugars	   or	   oligonucleotides39.	   RMI1	   injects	   a	   large	   insertion	   loop,	   located	  
between	  β1-­‐β2,	   into	   the	   central	   gate	  of	   the	   topoisomerase	   (fig	   1b,	   Supplementary	   fig	   4a).	   This	   loop,	  
was	   previously	   found	   disordered	   in	   the	   structure	   of	   isolated	   RMI1	   where	   it	   has	   been	   implicated	   in	  
TopIIIα	   binding	   (see	   below)29.	   The	   RMI1/TopIIIα	   arrangement	   places	   the	   RMI1	   insertion	   loop	   at	   the	  
center	  of	  the	  topoisomerase	  gate.	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Mechanism	  of	  single-­‐strand	  cleavage	  
TopIIIα	  crystalized	  in	  the	  presence	  of	  Magnesium	  (200mM	  MgCl2),	  or	  Calcium	  (Calcium	  Citrate	  200mM),	  
showed	  a	  strong	  positive	  fo-­‐fc	  density	  at	  the	  toprim	  acidic	  residues	  cluster	  (fig	  2a).	  We	  find	  that	  Mg2+	  and	  
Ca2+	   allow	   crystallization,	   and	   support	   catalysis40,	   while	   Zn2+	   or	   Cs2+	   were	   not	   tolerated	   in	   structural	  
studies.	  Due	  to	  the	  Mg2+	  dependence	  of	  DNA	  relaxation,	  the	  coordination	  chemistry	  observed	  and	  the	  
proximity	   of	   the	   density	   to	   the	   acidic	   cluster,	   we	   assigned	   the	   fo-­‐fc	   density	   as	  Mg2+	   (or	   Ca2+:	   for	   the	  
conditions	   involving	  high	  Calcium	  concentrations).	  The	  metal-­‐ion	   is	  hexa-­‐coordinated	   through	  5	  water	  
molecules	  and	  the	  carboxylic	  oxygen	  of	  E41.	  The	  hydroxyl	  group	  of	  Y362	  and	  carboxylic	  oxygen	  atoms	  of	  
E352,	   D150	   provide	   additional	   hydrogen	   bonds	   to	   bridging	  waters	  within	   the	   hydration	   shell	   (fig	   2a).	  
E352,	  conserved	  in	  all	  eukaryotic	  orthologues	  (fig2b	  and	  Supplementary	  fig	  2	  and	  3a)	  is	  not	  part	  of	  the	  
previously	   identified	   acidic	   cluster	   in	   E.	   coli	   topoisomerases,	   where	   it	   is	   substituted	   by	   a	   glutamine.	  
Other	   key	   residues	   serving	   comparable	   roles	   in	   eukaryotic	   and	   prokaryotic	   type	   IA	   enzymes	   include:	  
R364	  involved	  in	  pentavalent	  phosphate	  transition-­‐state	  stabilization,	  and	  H414	  implicated	  in	  anchoring	  
cut	  ssDNA	  to	  the	  (-­‐1)	  position41,42	  (fig.	  2b).	  	  
As	  previous	  prokaryotic	  type	  1A	  topoisomerase	  structures	  did	  not	  show	  signs	  of	  bound	  catalytic	  
metal	   ion,	   the	   TopIIIα-­‐RMI1	   structure	   now	   provides	   insight	   into	   type	   1A	   metal	   mediated	   ssDNA	  
cleavage:	   we	   find	   one	   Mg2+/Ca2+	   ion	   in	   our	   structure,	   with	   no	   indications	   of	   further	   binding	   sites.	  
Instead,	  a	  lysine	  residues	  (K42),	  conserved	  within	  the	  topoisomerase	  type	  1A	  family	  (fig2B)	  is	  situated	  at	  
the	  site	  equivalent	  to	  the	  secondary	  metal-­‐ion	  in	  TopII	  43.	  K42	  is	  ideally	  positioned	  to	  potentially	  stabilize	  
the	   negatively	   charged	  pentavalent	   phosphate	   transition	   state	   arising	   during	   trans-­‐esterification,	   thus	  
serving	   a	   functionally	   equivalent	   role.	  Our	   findings	   hence	   favor	   a	   one-­‐metal	   catalytic	  mechanism	  also	  
within	  the	  type	  1A	  family,	  as	  previously	  proposed43.	  	  
	  
TopIIIα	  resembles	  a	  prokaryotic	  type1A	  relaxase	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TopIIIα	  domains	   I,	   III	   and	   IV	   share	   close	   structural	   similarity	  with	   the	  Top1A	   relaxases	   from	  E.coli	   and	  
Thermatoga	  thermarum	  (rmsd:	  1.6-­‐1.7	  Å	  over	  480	  residues,	  Supplementary	  fig.	  2	  and	  3a),	  the	  similarity	  
with	  the	  E.coli	  Top3	  decatenase	  is	  less	  pronounced	  (rmsd:	  2.7	  Å)	  (fig	  3b).	  The	  most	  apparent	  differences	  
between	   TopIIIα	   and	   the	   prokaryotic	   Top3	   decatenases,	   however,	   are	   the	   absence	   of	   two	   insertion	  
loops	  equivalent	   to	  E.coli	   241-­‐255	   (E.	   coli	  Top3	  numbering:	  domain	   II)	   and	  502-­‐519	   (domain	   IV),	  both	  
lining	  the	  central	  cavity	  of	  the	  topoisomerase	  (fig	  3b).	  The	  latter	  has	  been	  implicated	  in	  decatenation	  in	  
the	  prokaryotic	  Top3	   family	   (and	   is	  henceforth	   referred	   to	  as	  decatenation	   loop)34,44.	   Thus	  TopIIIα,	  on	  
the	   structural	   level,	   has	   closer	   resemblance	   to	   a	   relaxase,	   not	   displaying	   obvious	   structural	   features	  
characteristic	  of	  prokaryotic	  type	  1A	  decatenases.	  	  
	  
The	  RMI1-­‐TopIII	  interface	  	  
RMI1	  OBN	  attaches	   to	   the	  TopIIIα	  gate	  acting	  as	   the	  major	  binding	   interface	  occupying	  a	   total	   surface	  
area	  of	  1564.8	  Å2.	  This	  interface	  is	  mainly	  hydrophobic	  in	  nature	  with	  acyl	  chains	  from	  RMI1	  L177,	  L181	  
(β4-­‐β5A	  loop),	  V179	  (β5A	  strand),	  the	  aromatic	  ring	  of	  Y151	  (β3-­‐β4	  loop)	  and	  methionines	  M134,	  M136	  
and	  M149	  (αI,	  β2	  strand	  and	  β3	  strands	  respectively)	  forming	  a	  hydrophobic	  zipper	  with	  TopIIIα	  L302,	  
L297,	  V298,	  L299	  and	  A295	  on	  α12,	  and	  L290	  on	  the	  β10-­‐α12	  loop	  (fig	  1C).	  These	  hydrophobic	  residues	  
form	  a	  hydrophobic	  groove	  that	  accommodates	  TopIIIα	  α12.	  A	  hydrogen	  bond	  network	  emanating	  from	  
RMI1	  OBN-­‐domain	  K78	  and	  R176	  (β4-­‐β5A)	  forms	  a	  salt	  bridge	  with	  TopIIIα	  E305	  further	  stabilizes	  binding	  
(fig.	  1d).	  	  
	  
The	  RMI1	  insertion	  loop	  inserts	  into	  the	  TopIIIα	  gate	  
We	  find	  that	  the	  RMI1	  loop,	  residues	  94	  to	  134,	  present	  as	  an	  insertion	  between	  β9	  and	  β10	  lines	  the	  
gate	  of	   the	   topoisomerase	   (fig	  1b,	  3a).	   In	   the	  TopIIIα-­‐RMI1	  complex,	   the	   loop	   is	   found	   in	   two	   slightly	  
different	  conformations.	  While	  being	  less	  ordered	  in	  the	  presence	  of	  Mg2+	  (Supplementary	  fig.	  4b)	  with	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an	  apparent	  discontinuity	  of	  the	  electronic	  density	  around	  residues	  120	  and	  131,	  it	  can	  be	  fully	  traced	  in	  
maps	  obtained	  from	  the	  crystals	  grown	  in	  the	  presence	  of	  Ca2+	   (fig.	  3a).	  The	  structure	  obtained	   in	  the	  
presence	  of	  Ca2+	  will	  subsequently	  be	  used	  as	  a	  basis	  for	  discussion.	  The	  RMI1	  insertion	  loop	  emanates	  
from	  β1	  (D94),	  and	  protrudes	  into	  the	  TopIIIα	  gate	  creating	  two	  layers	  of	  aligned	  and	  parallel	  rings	  (fig.	  
1b).	   In	   the	   conformational	   state	   trapped	   in	   the	   crystal,	   the	   RMI1	   insertion	   loop	   restricts	   the	   central	  
opening	   in	   the	  TopIIIα	   gate	   from	  25	  Å	   to	  13	  Å.	  As	   the	   single	   stranded	  DNA	  has	   to	  be	  moved	   into	   the	  
central	   cavity	   through	   an	   opening	   between	   domains	   I	   and	   III,	   the	   topoisomerase	   gate	   is	   effectively	  
closed/occupied	  by	  the	  RMI1	  loop	  (fig.	  1b).	  Further	  contacts	  between	  RMI1	  and	  TopIIIα	  are	  mediated	  by	  
RMI1	   αI,	   anchoring	   the	   loop	   at	   three	   main	   contact	   points	   (fig.	   1e,	   f),	   the	   majority	   of	   which	   are	  
hydrophobic	  in	  nature.	  	  
When	  examining	  the	  structure	  of	  the	  TopIIIα–RMI1	  complex,	  we	  noted	  that	  regions	  where	  the	  
TopIIIα	  structure	  diverges	  from	  the	  E.coli	  	  Top3	  decatenase,	  RMI1	  is	  found	  to	  donate	  structural	  motifs	  in	  
trans	   (fig.	   3a,b).	  We	   therefore	   focused	   on	   the	   RMI1	   insertion	   loop,	   examining	  whether	   decatenation	  
ability	  could	  principally	  be	  provided	  by	  structural	  motifs	  outside	  the	  core	  topoisomerase	  domain.	  	  
	  
The	  RMI1	  insertion	  loop	  is	  required	  for	  catenation	  and	  dHJ	  dissolution	  in	  vitro	  
In	   order	   to	   functionally	   dissect	   the	   contribution	   of	   the	   RMI1	   insertion	   loop	   within	   the	   TopIIIα-­‐RMI1	  
complex	   in	  vivo	  and	   in	  vitro,	  we	  switched	  to	  yeast	  as	  a	  model	  system.	   In	  comparison	  to	  the	  metazoan	  
RMI1	  orthologs,	  S.	   cerevisiae	  Rmi1	   is	  more	  divergent	   in	   sequence,	  whilst	   retaining	   the	  overall	  domain	  
organization	  of	   its	  metazoan	  orthologs	   (DUF1767	  +	  OBN	  +	   loop)	   (fig.	   c	  and	  Supplementary	   fig.	  3).	  The	  
corresponding	   segment	   loop	   is	   slightly	   extended	   spans	   58	   residues,	  with	   little	   apparent	   conservation	  
(fig.	  3c).	  We	  first	  tested	  whether	  the	  S.	  cerevisiae	  insertion	  loop	  can	  be	  deleted,	  or	  excised	  using	  flanking	  
TEV	  sites.	  All	   	  constructs	   tested	  resulted	   in	  Rmi1	  derivatives	  with	   limited	  solubility	  and	  defective	  Top3	  
binding	  (data	  not	  shown).	  We	  then	  replaced	  the	  58	  amino	  acid	  yeast	  Rmi1	  insertion	  loop	  (residues	  D87	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to	   V145)	  with	   23	   randomly	   scrambled	   residues	   taken	   from	   the	   human	  RMI1	   loop	   (fig.	   3c).	   This	   Rmi1	  
construct,	   designated	   randomized	   loop	   (rlRmi1),	   was	   found	   proficient	   in	   yeast	   Top3	   binding	  
(Supplementary	  fig.	  6a)	  and	  formed	  the	  basis	  for	  all	  subsequent	  biochemical	  experiments.	  	  
Isolated	  wild-­‐type	  Top3	  is	  able	  to	  relax	  negatively	  supercoiled	  DNA	  (scDNA)	  in	  presence	  of	  Mg2+	  
producing	   multiple	   relaxed	   DNA	   intermediates	   on	   ethidium	   bromide	   (EtBr)	   free	   gels	   (fig.	   4a,	   -­‐	   EtBr:	  
compare	   lanes	  1	  and	  2).	  Relaxation	   is	   inhibited	  by	  addition	  of	  Rmi1	   (lanes	  3	  to	  8).	  Running	  gels	   in	   the	  
absence	   of	   EtBr	   allows	   nicked	   DNA	   to	   be	   chromatographically	   separated	   from	   linear	   DNA.	   The	  
subsequent	  analysis	  (fig	  4a,	  +	  EtBr:	  lanes	  3	  to	  8)	  and	  quantification	  (fig	  4b)	  revealed	  a	  15-­‐fold	  increase	  in	  
the	  formation	  of	  nicked	  DNA,	  as	  a	  function	  of	  wild-­‐type	  Rmi1	  added.	  Previous	  work	  demonstrated	  that	  
the	  accumulation	  of	  nicked	  ssDNA	  species	  corresponds	  to	  Top3	  being	  stabilized	  in	  an	  ssDNA-­‐bound	  open	  
form,	  with	  the	  scissile	  phosphate	  covalently	  attached	  to	  the	  catalytic	  tyrosine	  of	  domain	  III23,24.	   	  When	  
using	  rlRmi1,	  however,	  an	  increase	  in	  nicked	  DNA,	  as	  function	  of	  added	  rlRmi1	  was	  not	  observed	  (fig	  4a,	  
+	  EtBr:	  lanes	  9	  to	  14;	  fig	  4b	  for	  quantification).	  Intriguingly,	  gels	  run	  without	  EtBr	  showed	  that	  relaxation	  
is	  still	  inhibited	  in	  the	  presence	  of	  rlRmi1	  (fig	  4a,	  -­‐	  EtBr:	  lanes	  9	  to	  14),	  as	  shown	  by	  the	  progressive	  loss	  
of	  the	  relaxed	  circular	  plasmid	  intermediates.	  	  
To	   rule	   out	   that	   rlRmi1	   renders	   Top3	   non-­‐functional	   in	   an	   unspecific	   fashion,	   for	   example	  
through	  aggregation,	  we	  next	  examined	  whether	  Rmi1	  also	  interferes	  with	  Top3	  mediated	  single	  strand	  
cleavage.	  We	   reasoned	   that	   a	   potential	   deleterious	   effect	   on	   Top3	   caused	   by	   the	   presence	   of	   rlRmi1	  
would	  also	  impair	  other	  Top3	  mediated	  reactions,	  such	  as	  single	  strand	  cleavage.	  For	  this,	  Top3-­‐rlRmi1	  
complexes	   were	   incubated	   with	   circular	   M13	   ssDNA	   viral	   DNA	   at	   400nM,	   the	   highest	   Rmi1	  
concentrations	  used	  in	  relaxation	  assays	  (fig.	  4d).	  Top3	  alone	  was	  able	  to	  effectively	  cleave	  ssDNA	  into	  
linear	   intermediates.	   	   In	   the	  presence	  of	   either	  wild-­‐type	  or	   rlRmi1,	  however,	   an	   identical	  behavior	   is	  
observed	  with	  comparable	  M13	  ssDNA	  cleavage	  (fig.	  4d,	   	  Supplementary	  fig.	  6b).	  As	   judged	  by	  single-­‐
strand	   cleavage,	   rlRmi1	   itself	   is	   thus	   not	   deleterious	   for	   Top3	   stability.	   We	   therefore	   conclude	   that	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effects	  on	  Top3	  catalysis	  observed	  in	  the	  presence	  of	  rlRmi1	  (fig	  4a)	  are	  likely	  a	  direct	  consequence	  of	  
loop	  sequence	  scrambling	  and	  shortening.	  These	  experiments	  demonstrate	  that	  the	  Rmi1	  insertion	  loop	  
is	   involved	   in	   stabilizing	  Top3	   in	  a	  nicked,	  open	  conformation,	  while	  not	   interfering	  with	   the	  principal	  
ability	  of	  Rmi1	  to	  inhibit	  Top3	  mediated	  relaxation.	  The	  insertion	  loop	  Rmi1	  hence	  directly	  influences	  the	  
open/closing	  equilibrium	  of	  the	  Top3	  gate.	  	  
	  
The	  RMI1	  insertion	  loop	  is	  a	  key	  element	  for	  dHJ	  dissolution	  in	  vitro	  	  
We	   next	   examined	   the	   effect	   of	   the	   loop	   on	   the	   catenation/decatenation	   process.	   For	   this	   purpose	  
concatenation	  of	  circular	  DNA	  into	  higher	  order	  catenanes	  was	  assayed	  using	  Top3,	  E.coli	  single	  strand	  
binding	  protein	  (SSB)	  and	  Sgs1	  in	  a	  reversible	  reaction	  previously	  characterized23,24.	  Catenation	  required	  
the	  concerted	  action	  of	  Top3	  and	  Sgs1	  in	  an	  ATP-­‐dependent	  reaction.	  To	  examine	  the	  effect	  of	  the	  Rmi1	  
insertion	  loop	  on	  catenation,	  wild-­‐type	  Rmi1	  or	  rlRmi1	  were	  titrated	  into	  the	  reaction	  mixture	  (fig.	  4b).	  
We	  observed	  that	  wild-­‐type	  Rmi1	  stimulated	  catenation	  (lanes	  3-­‐6),	  as	  evident	  by	  the	  emergence	  of	  low	  
velocity	  migrating	  species.	  rlRMI1,	  on	  the	  other	  hand,	  did	  not	  result	  in	  increased	  formation	  of	  catenation	  
products	   as	   function	  of	   protein	   added	   (200	  and	  400nM)	   (fig	   4b,	   lanes	  7-­‐10).	   The	  RMI1	   insertion	   loop	  
hence	  not	  only	  influences	  the	  opening/closure	  equilibrium	  of	  the	  topoisomerase,	  but	  is	  also	  required	  for	  
catenation/decatenation	  and	  will	  hence	  subsequently	  be	  referred	  to	  as	  decatenation	  loop.	  	  
	   As	  catenation	  is	  not	  the	  presumed	  biological	  role	  of	  the	  Top3-­‐Rmi1	  complex	  we	  next	  examined	  
the	   concerted	   action	   of	   Top3	   and	   Sgs1	   in	   dissolution	   of	   synthetic	   double	   holliday	   junctions	   (fig.	   4e).	  
Wild-­‐type	  Rmi1	   strongly	   stimulated	   the	  dissolution	  of	  dHJ	  by	   the	  Top3-­‐Rmi1	  complex,	   resulting	   in	   the	  
same	   amount	   of	   radiolabelled	   dissolution	   product	   compared	   to	   a	   control	  where	   the	   dHJ	   substrate	   is	  
cleaved	  by	  the	  RsaI	  restriction	  enzyme,	  as	  previously	  observed24,25.	  When	  wild-­‐type	  Rmi1	  is	  substituted	  
for	  rlRmi1,	  the	  dissolution	  efficiency	   is	   largely	   impaired	  yielding	  similar	  amounts	  than	  that	  observed	  in	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the	   absence	  of	   Rmi1.	   This	   strongly	   suggests	   that	   the	  decatenation	   loop	   and	   its	   ability	   to	   stabilize	   the	  
open-­‐state	  and	  facilitate	  catenation/decatenation	  is	  also	  required	  for	  dHJ	  dissolution	  in	  vitro.	  	  
	  
The	  Rmi1	  decatenation	  loop	  is	  required	  for	  dissolvasome	  function	  in	  vivo.	  
In	   order	   to	   examine	   the	  biological	   significance	  of	   rlRmi1	   in	   vivo,	  we	   generated	   a	   genetically	  modified	  
yeast	  strain	  where	  the	  rmi1	  gene	  has	  been	  substituted	  through	  a	  rlRmi1	  version.	  ΔRmi1	  strains	  exhibit	  
high	  sensitivity	  to	  methyl	  methanesulfonate	  (MMS)	  (fig.	  4f).	  MMS	  forms	  DNA	  adducts	  which	  in	  turn	  give	  
rise	  to	  DSBs	  and	  activate	  a	  HR	  repair	  response45,46.	  To	  avoid	  accumulation	  of	  suppressors,	  we	  maintained	  
strains	   in	   a	   diploid	   state	   and	   performed	   the	  MMS	   sensitivity	   test	   on	   freshly	   dissected	   tetrad	  mutant	  
spores.	   ΔRmi1	   strain	   exhibit	   slow	   growth	   and	   MMS	   sensitivity	   in	   the	   presence	   of	   0,012%	   MMS	   as	  
described	  previously	  18,22.	  Yeast	  cells	  having	  undergone	  Rmi1	  deletion	  and	  gene	  replacement	  with	  rlRmi1	  
show	  sensitivity	  at	  0,012%	  MMS	  exposure	  similar	  to	  that	  of	  the	  ΔRmi1	  strain,	  as	  well	  as	  a	  slow	  growth	  
phenotype	   (fig.	   4f).	   This	   phenotype	   implies	   that	   a	   defect	   in	   the	   decatenation	   loop	   is	   sufficient	   to	  
emulate	  the	  ΔRmi1	  phenotype	  and	  suggests	  that	  the	  decatenation	  loop	  is	  required	  in	  vivo	  for	  dissolution	  
of	   homologous	   recombination	   repair	   intermediates.	   In	   conclusion,	   the	   Rmi1	   decatenation	   loop	   is	  
required	   for	   modulating	   the	   Top3	   open/closure	   equilibrium	   and	   for	   conversion	   of	   Top3	   into	   a	  
decatenating	   enzyme	   allowing	   HJ	   dissolution,	   and	   in	   vivo	   resolution	   of	   otherwise	   toxic	   repair	  
intermediates.	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Discussion	  
Type	  1A	  topoisomerases	  operate	  in	  the	  context	  of	  larger	  macromolecular	  assemblies.	  One	  of	  the	  most	  
prominent	   examples	   is	   the	   eukaryotic	   topoisomerase	   III	   family,	   responsible	   for	   non-­‐crossover	   dHJ	  
resolution	   in	   concert	   with	   a	   dedicated	   RecQ-­‐type	   helicase	   and	   RMI1.	   How,	   on	   the	   structural	   and	  
mechanistic	  level,	  topoisomerase	  action	  is	  governed	  by	  the	  toposome,	  is	  a	  key	  question.	  
	  
RMI1	  injects	  structural	  epitope	  that	  influences	  the	  topoisomerase	  cycle	  
We	   have	   determined	   the	   structure	   of	   the	   human	   TopIIIα-­‐RMI1(OBN)	   complex	   finding	   strong	  
resemblance	   between	   TopIIIα	   and	   a	   prokaryotic	   type	   1A	   relaxase.	   Decatenation	   is	   dependent	   on	   the	  
RMI1	  decatenation	  loop	  segment,	  which	  is	  donated	  in	  trans	  into	  the	  central	  gate	  of	  the	  topoisomerase.	  
In	  order	  to	   illustrate	  what	  may	  happen	   in	  the	  TopIIIα-­‐RMI1	  reaction	  cycle,	  we	  built	  a	  TopIIIα	  model	   in	  
different	  stages	  of	  decatenation,	  based	  on	  previous	  structures	  and	  normal	  modes	  simulations	  available	  
for	  E.coli	  Top1A47,48.	  This	  model	  depicts	  domain	  III	  and	  the	  gate	  in	  a	  presumed	  open	  conformation	  (fig.	  
5),	  and	  suggests	  that	  gate	  may	  create	  an	  opening	  of	  up	  to	  30	  Å	   in	  width,	  analogous	  to	  what	  has	  been	  
suggested	  for	  E.coli	  TopIA47.	  In	  the	  presence	  of	  RMI1,	  however,	  steric	  hindrance	  imparted	  by	  the	  mobile	  
part	  of	  the	  RMI1	  insertion	  loop	  (V116-­‐P131,	  fig.	  3a)	  is	  expected	  to	  restrict	  gate	  opening	  and	  impact	  re-­‐
closure	  of	  the	  gate.	  Our	  biochemical	  data	  are	  consistent	  with	  the	  RMI1	  decatenation	  loop	  being	  involved	  
in	  stabilization	  of	  the	  open	  state,	  following	  nicking	  of	  the	  C-­‐strand	  (fig.	  5).	  By	  scrambling	  the	  sequence	  
and	   shortening	   the	   loop	   length,	   we	   find	   that	   the	   loop	   is	   required	   to	   maintain	   the	   loop	   in	   an	   open	  
conformation.	   Whether	   this	   open	   state	   observed	   biochemically	   depicts	   gate	   opening	   while	   single	  
stranded	   DNA	   from	   the	   T-­‐strand	   is	   being	   accommodated	   (potentially	   stabilized	   by	   a	   ssDNA-­‐RMI1	  
decatenation	   loop	   interaction)	   and/or	  whether	   the	   empty	   gate	   is	   being	  mainly	   held	   open	   to	   provide	  
sufficient	   time	   to	   encounter	   the	   T-­‐strand	   which	   decatenation	   has	   to	   provided	   in	   a	   intra-­‐molecular	  
fashion	  can	  not	  be	  resolved	  at	  present.	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It	   is	  of	  note	   that	   for	   the	   topoisomerase	   cycle	   to	  be	   completed,	   the	  T-­‐strand	  has	   to	  be	  moved	  
through	   the	  C-­‐strand	  nick,	   followed	  by	  C-­‐strand	   religation	   and	   subsequent	   T-­‐strand	   release	   (fig.	   5).	   A	  
certain	   degree	   of	   plasticity	  within	   the	   decatenation	   loop	   is	   thus	   required	   to	   accommodate	   the	   single	  
strand	  DNA	  upon	  gate	  closure,	  as	  the	  cavity	  between	  the	  decatenation	  loop	  and	  the	  topoisomerase	  gate	  
only	  measures	  around	  11	  Å	  at	   its	  widest	  point	   (with	  the	  diameter	  of	  ssDNA	  being	  approximately	  7	  Å).	  
This	  is	  in	  line	  with	  the	  plasticity	  of	  the	  decatenation	  loop	  observed	  when	  comparing	  the	  Mg2+	  and	  Ca2+	  
crystal	   forms	   (fig.	   3a,	   Supplementary	   fig.	   4b).	   In	   the	   Mg2+	   bound	   structure	   the	   loop	   segment	   is	  
disordered	  around	  the	  presumed	  ssDNA	  T-­‐strand	  binding	  site	  (residues	  116	  to	  131).	  In	  the	  model	  of	  the	  
open	  form	  we	  further	  observe	  that	  the	  pivot	  region	  of	  the	  gate	  is	  in	  close	  proximity	  to	  the	  beginning	  of	  
the	  decatenation	  loop	  (residues	  P98-­‐Y100)	  hence	  providing	  a	  potential	  mechanism	  of	  how	  RMI1	  binding	  
could	   influence	   the	   TopIIIα	   open-­‐close	   equilibrium.	   Due	   to	   the	   steric	   constraint	   imparted	   by	   the	  
presence	  of	  the	  RMI1	  decatenation	  loop	  with	  the	  topoisomase	  gate,	  dsDNA	  accommodation	  within	  the	  
TopIIIα	   gate	   is	   unlikely.	   This	   is	   in	   agreement	   with	   the	   low	   efficiency	   (~10	   fold)	   by	   which	   dsDNA	   is	  
accommodated	  by	  the	  Top3-­‐Rmi1	  in	  decatenation	  experiments23,	  and	  in	  contrast	  to	  the	  behavior	  seen	  in	  
prokaryotic	  Top3	  enzymes49.	  
	  
Towards	  a	  unified	  decatenation	  mechanism	  of	  eukaryotic	  and	  prokaryotic	  topoisomerases	  
The	   TopIIIα-­‐RMI1	   system	   bears	   the	   conceptual	   advantage	   that	   decatenation	   is	   dependent	   on	   RMI1	  
addition	   in	  trans,	  allowing	  to	  directly	  probe	  the	  effect	  of	  RMI1	  on	  decatenation,	  without	  manipulating	  
the	   topoisomerase.	  Prokaryotic	   type	   IA	   topoisomerases	   implicated	   in	   relaxation	  and	   those	   involved	   in	  
decatenation	   (e.g.:	   E.	   coli	   Top3),	   share	   almost	   identical	   enzymatic	   cores	  with	   only	  minimal	   structural	  
differences,	  the	  most	  significant	  being	  the	  decatenation	  loop,	  lining	  the	  gate,	  which	  is	  exclusively	  found	  
in	  the	  prokaryotic	  decatenases34.	  Deletion	  of	  this	  loop	  in	  E.coli	  Top3,	  results	  in	  almost	  complete	  loss	  of	  
decatenation,	  albeit	  with	  relaxation	  also	  being	   impaired44.	  The	  structural	  equivalent	  to	  this	   loop	  in	  the	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eukaryotic	   Top3/TopIIIα	   decatenases	   are	   absent,	   which	   has	   previously	   been	   used	   as	   an	   argument	  
against	   loop	  mediated	   decatenation.	  We	   now	   find	   that	   RMI1	   is	   inserts	   a	   decatenation	   loop	   in	   trans,	  
positioned	  at	  a	   similar	   loci	   than	   the	  prokaryotic	  decatenation	   loop.	  Moreover	   this	   loop	   is	   required	   for	  
effective	  decatenation	  and	  dHJ	  resolution.	  	  
	   Taken	  together,	  we	  propose	  a	  model	  (fig.	  5)	  where,	  following	  binding	  and	  scission	  of	  the	  single	  
strand	  C-­‐strand,	  the	  topoisomerase	  gate	  opens.	  The	  gate	  in	  its	  open	  form	  is	  stabilized	  through	  the	  RMI1	  
decatenation	   loop	   (or	   the	   functionally/structurally	   equivalent	   loop	   found	   in	   prokaryotic	   type	   IA	  
enzymes).	  The	  structure	  supports	  a	  model	  where	  the	  gate	  in	  its	  stabilized	  cut/open	  state	  will	  provide	  the	  
toposome	   with	   sufficient	   time	   to	   accommodate	   distant	   ssDNA	   T-­‐strands	   originating	   from	   different	  
duplexes	  (e.g.	  in	  dHJ	  dissolution)	  moving	  these	  strands	  in/out	  of	  the	  gate,	  thereby	  driving	  decatenation	  
(as	  an	  ‘inter-­‐molecular	  process’)	  23.	  In	  relaxation,	  on	  the	  other	  hand,	  where	  the	  T-­‐strand	  belongs	  to	  the	  
same	  duplex	  as	   the	  C-­‐strand	   (working	   in	   an	   intra-­‐molecular	  process)	  movement	  of	  DNA	   strands	   likely	  
occurs	  over	  shorter	  distances	  hence	  not	  requiring	  extended	  gate	  opening	  times.	  While	  we	  find	  that	  the	  
RMI1	   decatenation	   loop	   is	   required	   for	   this	   process,	   we	   can	   exclude	   that	   other	   part	   of	   the	  
topoisomerase	   are	   involved	   in	   the	   reaction,	   such	   as	   the	   divergent	   Top3	   C-­‐termini	   observed	   in	  
prokaryotes	  and	  eukaryotes.	  
	  	  
TopIIIα -­‐RMI1	  function	  in	  the	  dissolvasome	  
dHJ	   dissolution	   is	   dependent	   on	   the	   presence	   of	   a	   complete	   dissolvasome	   consisting,	   minimally,	   of	  
Top3/IIIα,	   Rmi1/RMI1	   and	   a	   RecQ	   helicase.	   In	   yeast	   dissolution,	   the	   Sgs1	   RecQ	   helicase	   serves	   a	  
catalytic,	   as	   well	   as	   a	   non-­‐catalytic	   scaffolding	   role.	  We	   now	   find	   that	   RMI1	   does	   not	   fundamentally	  
change	   the	  mode	  of	   topoisomerase	   action,	   but	   rather	  modulates	   its	   dynamics.	   In	   the	   simplest	  model	  
(Supplementary	  fig.	  7),	  assuming	  a	  1:1:1	  complex	  of	  Rmi1/RMI1:Top3/IIIα:Sgs1/BLM	  (see	  accompanying	  
paper),	   the	   duplex	   undergoes	   strand-­‐separation	   through	   the	   helicase,	   with	   one	   strand	   being	   guided	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through	   the	   gate	   (equivalent	   to	   the	   T-­‐strand	   position),	   while	   the	   other	   is	   being	   nicked	   by	   the	  
topoisomerase	   around	   the	   C-­‐strand.	   In	   this	   manner	   helicase	   and	   topoisomerase	   action	   can	   be	  
coordinated	   releasing	   topological	   strain	   during	   branch	   migration,	   and	   the	   RecQ	   helicase	   within	   the	  
complex	  can	  plays	  a	  non-­‐catalytic	  scaffolding	  effect	  guiding	  at	  least	  one	  of	  the	  single	  strand	  to	  the	  C-­‐/T-­‐
site	  of	  the	  topoisomerase.	  Whether	  a	  higher	  order	  structure	  exists	  driving	  convergent	  branch	  migration	  
of	  two	  dHJ	  junctions	  (likely	  involving	  4	  dissolvasome	  complexes)	  and	  what	  such	  super-­‐complex	  may	  look	  
like	  is	  unclear	  at	  the	  moment.	  	  
Conclusion	  
We	   herein	   provide	   molecular	   insight	   into	   the	   mechanistic	   influence	   of	   the	   large	   molecular	   complex	  
environment,	  the	  toposome,	  on	  topoisomerase	  action.	  It	  will	  be	  exciting	  to	  study	  how	  other	  accessory	  
components	  such	  RPA,	  or	  related	  complexes	  such	  Fanconi	  and	  Rif1	  do	  impact	  on	  dissolvasome	  function.	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Methods	  
Protein	   expression	   prior	   crystallization	   The	   human	   TopIIIα	   (residues	   1-­‐753)/RMI1	   (residues	   1-­‐219)	  
complex	  is	  co-­‐expressed	  in	  High	  5	  insect	  cells	  using	  a	  pFast-­‐Bac	  vector	  (Invitrogen).	  Cells	  are	  infected	  at	  
a	  4	  million/ml	  concentration	  and	  harvested	  after	  48	  hours	  expression.	  Lysis	  (lysis	  buffer:Tris	  pH8	  50mM,	  
NaCl	   200	   mM,	   βMe	   1mM,	   PMSF	   1	   mM	   and	   Sigma	   Proteases	   inhibitors	   cocktail)	   is	   performed	   by	  
sonication	  followed	  by	  clarification	  of	  the	  lysate	  by	  ultracentrifugation.	  Streptactin	  affinity	  purification	  is	  
performed	  as	  a	  first	  strep	  affinity	  step,	  followed	  by	  POROSQ	  Ion	  exchange	  chromatography	  (Buffers	   in	  
Tris	  pH8	  50mM	  and	  TCEP	  0,2	  mM)	   removing	   traces	   	  of	  endogenous	  DNA.	  As	  a	   final	   step,	   the	  purified	  
protein	  was	   subjected	   to	  a	   size	  exclusion	  chromatography	  on	  a	  Superdex	  200	  column	   (GE	  healthcare)	  
(HEPES	   pH7,4	   50mM,	   NaCl	   300mM	   and	   TCEP	   0,2	   mM).	   Fractions	   corresponding	   to	   a	   monomeric	  
heterodimer	  with	  appropriate	  ratio	  are	  pooled	  and	  subjected	  to	  further	  crystallization	  experiments.	  
	  
Complex	  crystallization	  The	  complex	  (8mg/ml)	  has	  been	  crystallized	  in	  PEG2000	  8-­‐12%,	  Tris	  pH7	  0,1	  M,	  
and	  MgCl2	  0,2M.	  Crystals	  grew	  only	  in	  the	  presence	  of	  Mg2+	  or	  Ca2+.	  The	  conditions	  of	  crystallization	  for	  
the	  crystals	  grown	  in	  presence	  of	  Ca2+	  are,	  Tris	  pH7.0,	   	  0.1	  M,	  PEG	  5k	  MME	  8%,	  Calcium	  citrate	  0.2	  M.	  
Crystals	   in	   either	  Mg2+	  or	  Ca2+	   appeared	   square	  based	   rods	   growing	   to	  maximal	  dimension	  within	  4-­‐5	  
days	  and	  belong	  to	  the	  tetragonal	  family	  (P41212	  space	  group)	  with	  	  one	  heterodimer	  in	  the	  asymmetric	  
unit.	   Cryopreservation	   of	   crystals	  was	   performed	   by	   supplementation	   of	   the	  mother	   solution	   by	   35%	  
Ethylene	  glycol	  prior	  flash	  frozing	  in	  liquid	  nitrogen.	  
Structure	  Determination	  	  Final	  datasets	  have	  been	  recorded	  at	  the	  SLS	  on	  the	  PXII	  beamline	  (Villigen)	  at	  
a	   wavelength	   of	   1.0	   Å.	   Data	   sets	   from	   Mg2+	   and	   Ca2+	   conditions	   were	   processed	   by	   XDS50	   and	   the	  
structure	   solved	   by	   molecular	   replacement	   using	   PHASER51.	   An	   initial	   search	   has	   been	   made	   with	   a	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model	  of	  E.	  coli	  Top1A	  proposed	  by	  BALBES	  server,	  and	  sequence	  optimized	  by	  CHAINSAW	  software52.	  
Then	  a	  second	  one	  with	  the	  hRMI1	  structure	  with	  the	  top1A	  as	  a	  fixed	  model.	  	  
Refinement.	  The	  initial	  	  phases	  have	  further	  been	  refined	  using	  a	  combination	  of	  PHENIX53,	  REFMAC554	  
and	  BUSTER55	   software,	   in	   addition	  with	   TLS	   constraints.	  During	  map	   inspection,	   it	   turns	  out	   that	   the	  
RMI1	   insertion	   loop	  (residues	  116-­‐130)	  was	  more	  ordered	  and	  resolved	   in	  the	  Calcium	  datas	  although	  
the	  datas	  were	  of	   a	   lower	   average	  quality	   (See	  Supplementary	  Table	  1)	   showing	   continuous	  electron	  
density	   all	   along	   the	   loop	   allowing	   unambiguous	   building.	   The	   final	   refined	  models	   (Rwork/Rfree	   (%)	   for	  
TopIIIα-­‐Mg2+	  are	  20.2/22.6	  and	  for	  TopIIIα-­‐Ca2+,	  20.9/22.8)	  contains	  residues	  RMI	  2-­‐216	  and	  TopIIIα	  20-­‐
637	  and	  one	  heteroatom	  of	  Mg2+	  or	  Ca2+,	  additional	  pieces	  of	  the	  TopIIIα	  N-­‐	  and	  C-­‐terminus	  are	  partially	  
visible	   but	   could	   not	   be	   univocally	   traced	   and	   assigned	   and	  were	   omitted	   from	   the	  model.	   The	   final	  
Ramachandran	   statistics	   are	   %favoured/%outliers,	   for	   TopIIIα-­‐Mg2+	   (97.1/0)	   and	   for	   TopIIIα-­‐Ca2+	  
(96.1/0.1).	  
Relaxation,	  catenation	  and	  M13	  digest	  assays	  with	  yeast	  proteins.	  Yeast	  Top3,	  Sgs1	  and	  bacterial	  SSB	  
are	  generous	  gift	   from	  Petr	  Cejka.	  Yeast	  Rmi1	  wt	  and	  rl	  constructs	  have	  been	  expressed	   in	   insect	  cells	  
(High	  5)	  as	  GST-­‐Nterm	  fusion	  proteins	  and	  Cterm	  His	  tag	  following	  the	  previously	  described	  protocole	  of	  
lysis	   to	   avoid	   nucleases	   contamination.	   Final	   buffer	   for	   protein	   storage	   is	   Tris	   pH	   7.5	   50	   mM,	   NaCl	  
150mM,	  βMe	  1	  mM,	  10%	  glycerol.	  (Final	  buffer)	  
For	   relaxation	   assay,	   proteins	   (Top3	   and	   different	   RMI1	   constructs)	   are	   incubated	   in	   presence	   of	  
subtrate	  PUC19	  (200ng	  per	  reaction)	  and	  incubated	  1h	  at	  42°C	  in	  a	  reaction	  buffer,	  HEPES	  pH7.4	  25mM,	  
BSA	  100µg/ml,	  Glycerol	  32%,	  NaOc	  5mM,	  MgOAc	  0,5mM.	  The	  reaction	   is	   then	  stopped	  by	  addition	  of	  
EDTA	  and	  Proteinase	  K	  for	  1hour	  at	  37°C.	  The	  samples	  are	  loaded	  on	  1%	  agarose	  gel	  poored	  in	  presence	  
or	  not	  of	  Ethydium	  Bromide.	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For	  catenation	  assay24,	  Sgs1	  (160nM)	  and	  SSB	  are	  added	  in	  the	  reaction	  and	  the	  reaction	  buffer	  differs	  as	  
the	  ATPase	   activity	   of	   Sgs1	   is	   required,	   Tris	   pH	   7.5	   25	  mM,	  MgOAc	   1mM,	  DTT	   0.1	  mM,	   Phosphoenol	  
pyruvate	  1mM,	  Pyruvate	  kinase	  80U/ml,	  BSA	  100µg/ml	  and	  ATP	  1mM.	  The	  reactions	  are	   incubated	  at	  
37°C	  for	  1	  hour	  and	  stopped	  as	  described	  above.	  	  
The	  M13	  (200ng	  per	  reaction,	  M13	  mp18	  phage	  ssDNA	  from	  Clontech)	  digest	  has	  been	  done	  in	  the	  same	  
conditions	  than	  the	  relaxation	  assay.	  The	  gel	  is	  stained	  with	  SYBR	  green.	  	  
Holliday	   junction	   dissolution	   assay.	  The	   human	   RMI1	   loop	   variants	   have	   been	   generated	   by	   classical	  
mutagenesis	  strategy,	  cloned	  in	  pGEX	  plasmids	  and	  produced	  in	  E.coli	  ROSETTA	  strain	  (OVN	  expression	  
at	   20°C,	   0.2mM	   IPTG).	   The	   cells	   are	   harvested	   and	   lysed	   by	   sonification	   .	   After	   ultracentrifugation	  
clarification,	  a	  GST	   sepharose	  affinity	   strep	   is	  performed	   followed	  by	  a	  OVN	  TEV	  cleavage	   (4°C,	  2%	  of	  
TEV	  protease).	  RMI1	  protein	   is	   further	  purified	  by	  a	  POROS	  Q	   ion	  exchange	   chromatography	  allowing	  
the	   separation	   of	   GST	   tag	   (elution	   around	   140mM	   salt)	   from	   RMI1	   (elution	   around	   200mM).	   The	  
proteins	  are	  then	  dialysed	  overnight	  against	  final	  buffer.	  
Yeast	  strain	  generation	  and	  drug	  sensitivity	  test.	  
	  
ΔRmi1	  and	  Rmi1rl	  	  strains	  have	  been	  2	  times	  backcrossed	  with	  the	  yeast	  WT303.	  The	  obtained	  mutants	  
clones	  were	  mated	  with	  the	  WT303	  and	  big	  diploid	  colonies	  were	  selected	  and	  placed	  on	  a	  sporulation	  
plates.	  5	  to	  10	  tetrads	  were	  dissected	  and	  smaller	  clones	  were	  picked	  for	  MMS	  test.	  
O/N	  cultures	  from	  the	  smaller	  colonies	  were	  diluted	  to	  OD600	  =	  0.5	  and	  grow	  for	  4h	  at	  37°C.	  The	  ODs	  
were	  set	  to	  0.1	  and	  step	  diluted	  (1/10)	  5	  times.	  YPAD	  +	  MMS	  0.012%	  plates	  were	  freshly	  prepared	  and	  
dried	  15	  min	  at	  37°C.	  4	  ml	  drops	  of	  each	  dilution	  are	  plated.	  The	  plate	  are	  placed	  at	  30°C	  for	  48h.	  
	   	  
	   	   23	  
References	  
1.	   Petermann,	  E.	  &	  Helleday,	  T.	  Pathways	  of	  mammalian	  replication	  fork	  restart.	  Nature	  reviews.	  
Molecular	  cell	  biology	  11,	  683-­‐7	  (2010).	  
2.	   Moynahan,	  M.E.	  &	  Jasin,	  M.	  Mitotic	  homologous	  recombination	  maintains	  genomic	  stability	  and	  
suppresses	  tumorigenesis.	  Nature	  reviews.	  Molecular	  cell	  biology	  11,	  196-­‐207	  (2010).	  
3.	   Holliday,	  R.	  A	  mechanism	  for	  gene	  conversion	  in	  fungi.	  Genetical	  research	  89,	  285-­‐307	  (2007).	  
4.	   Szostak,	  J.W.,	  Orr-­‐Weaver,	  T.L.,	  Rothstein,	  R.J.	  &	  Stahl,	  F.W.	  The	  double-­‐strand-­‐break	  repair	  
model	  for	  recombination.	  Cell	  33,	  25-­‐35	  (1983).	  
5.	   Heyer,	  W.D.,	  Ehmsen,	  K.T.	  &	  Solinger,	  J.A.	  Holliday	  junctions	  in	  the	  eukaryotic	  nucleus:	  
resolution	  in	  sight?	  Trends	  in	  biochemical	  sciences	  28,	  548-­‐57	  (2003).	  
6.	   Matos,	  J.,	  Blanco,	  M.G.,	  Maslen,	  S.,	  Skehel,	  J.M.	  &	  West,	  S.C.	  Regulatory	  control	  of	  the	  resolution	  
of	  DNA	  recombination	  intermediates	  during	  meiosis	  and	  mitosis.	  Cell	  147,	  158-­‐72	  (2011).	  
7.	   Heyer,	  W.D.	  Recombination:	  Holliday	  junction	  resolution	  and	  crossover	  formation.	  Current	  
biology	  :	  CB	  14,	  R56-­‐8	  (2004).	  
8.	   Cavenee,	  W.K.	  et	  al.	  Expression	  of	  recessive	  alleles	  by	  chromosomal	  mechanisms	  in	  
retinoblastoma.	  Nature	  305,	  779-­‐84	  (1983).	  
9.	   Thiagalingam,	  S.	  et	  al.	  Mechanisms	  underlying	  losses	  of	  heterozygosity	  in	  human	  colorectal	  
cancers.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  98,	  
2698-­‐702	  (2001).	  
10.	   LaRocque,	  J.R.	  et	  al.	  Interhomolog	  recombination	  and	  loss	  of	  heterozygosity	  in	  wild-­‐type	  and	  
Bloom	  syndrome	  helicase	  (BLM)-­‐deficient	  mammalian	  cells.	  Proceedings	  of	  the	  National	  
Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  108,	  11971-­‐6	  (2011).	  
11.	   Wu,	  L.	  &	  Hickson,	  I.D.	  The	  Bloom's	  syndrome	  helicase	  suppresses	  crossing	  over	  during	  
homologous	  recombination.	  Nature	  426,	  870-­‐4	  (2003).	  
12.	   Gangloff,	  S.,	  McDonald,	  J.P.,	  Bendixen,	  C.,	  Arthur,	  L.	  &	  Rothstein,	  R.	  The	  yeast	  type	  I	  
topoisomerase	  Top3	  interacts	  with	  Sgs1,	  a	  DNA	  helicase	  homolog:	  a	  potential	  eukaryotic	  reverse	  
gyrase.	  Molecular	  and	  cellular	  biology	  14,	  8391-­‐8	  (1994).	  
13.	   Bennett,	  R.J.,	  Noirot-­‐Gros,	  M.F.	  &	  Wang,	  J.C.	  Interaction	  between	  yeast	  sgs1	  helicase	  and	  DNA	  
topoisomerase	  III.	  The	  Journal	  of	  biological	  chemistry	  275,	  26898-­‐905	  (2000).	  
14.	   Fricke,	  W.M.,	  Kaliraman,	  V.	  &	  Brill,	  S.J.	  Mapping	  the	  DNA	  topoisomerase	  III	  binding	  domain	  of	  
the	  Sgs1	  DNA	  helicase.	  The	  Journal	  of	  biological	  chemistry	  276,	  8848-­‐55	  (2001).	  
15.	   Harmon,	  F.G.,	  DiGate,	  R.J.	  &	  Kowalczykowski,	  S.C.	  RecQ	  helicase	  and	  topoisomerase	  III	  comprise	  
a	  novel	  DNA	  strand	  passage	  function:	  a	  conserved	  mechanism	  for	  control	  of	  DNA	  
recombination.	  Molecular	  cell	  3,	  611-­‐20	  (1999).	  
16.	   Cejka,	  P.	  &	  Kowalczykowski,	  S.C.	  The	  full-­‐length	  Saccharomyces	  cerevisiae	  Sgs1	  protein	  is	  a	  
vigorous	  DNA	  helicase	  that	  preferentially	  unwinds	  holliday	  junctions.	  The	  Journal	  of	  biological	  
chemistry	  285,	  8290-­‐301	  (2010).	  
17.	   Xu,	  D.	  et	  al.	  RMI,	  a	  new	  OB-­‐fold	  complex	  essential	  for	  Bloom	  syndrome	  protein	  to	  maintain	  
genome	  stability.	  Genes	  &	  development	  22,	  2843-­‐55	  (2008).	  
18.	   Mullen,	  J.R.,	  Nallaseth,	  F.S.,	  Lan,	  Y.Q.,	  Slagle,	  C.E.	  &	  Brill,	  S.J.	  Yeast	  Rmi1/Nce4	  controls	  genome	  
stability	  as	  a	  subunit	  of	  the	  Sgs1-­‐Top3	  complex.	  Molecular	  and	  cellular	  biology	  25,	  4476-­‐87	  
(2005).	  
19.	   Singh,	  T.R.	  et	  al.	  BLAP18/RMI2,	  a	  novel	  OB-­‐fold-­‐containing	  protein,	  is	  an	  essential	  component	  of	  
the	  Bloom	  helicase-­‐double	  Holliday	  junction	  dissolvasome.	  Genes	  &	  development	  22,	  2856-­‐68	  
(2008).	  
20.	   Raynard,	  S.,	  Bussen,	  W.	  &	  Sung,	  P.	  A	  double	  Holliday	  junction	  dissolvasome	  comprising	  BLM,	  
topoisomerase	  IIIalpha,	  and	  BLAP75.	  The	  Journal	  of	  biological	  chemistry	  281,	  13861-­‐4	  (2006).	  
	   	   24	  
21.	   Lai,	  M.S.,	  Seki,	  M.,	  Ui,	  A.	  &	  Enomoto,	  T.	  Rmi1,	  a	  member	  of	  the	  Sgs1-­‐Top3	  complex	  in	  budding	  
yeast,	  contributes	  to	  sister	  chromatid	  cohesion.	  EMBO	  reports	  8,	  685-­‐90	  (2007).	  
22.	   Chang,	  M.	  et	  al.	  RMI1/NCE4,	  a	  suppressor	  of	  genome	  instability,	  encodes	  a	  member	  of	  the	  RecQ	  
helicase/Topo	  III	  complex.	  The	  EMBO	  journal	  24,	  2024-­‐33	  (2005).	  
23.	   Cejka,	  P.,	  Plank,	  J.L.,	  Dombrowski,	  C.C.	  &	  Kowalczykowski,	  S.C.	  Decatenation	  of	  DNA	  by	  the	  S.	  
cerevisiae	  Sgs1-­‐Top3-­‐Rmi1	  and	  RPA	  complex:	  a	  mechanism	  for	  disentangling	  chromosomes.	  
Molecular	  cell	  47,	  886-­‐96	  (2012).	  
24.	   Cejka,	  P.,	  Plank,	  J.L.,	  Bachrati,	  C.Z.,	  Hickson,	  I.D.	  &	  Kowalczykowski,	  S.C.	  Rmi1	  stimulates	  
decatenation	  of	  double	  Holliday	  junctions	  during	  dissolution	  by	  Sgs1-­‐Top3.	  Nature	  structural	  &	  
molecular	  biology	  17,	  1377-­‐82	  (2010).	  
25.	   Chen,	  C.F.	  &	  Brill,	  S.J.	  Binding	  and	  activation	  of	  DNA	  topoisomerase	  III	  by	  the	  Rmi1	  subunit.	  The	  
Journal	  of	  biological	  chemistry	  282,	  28971-­‐9	  (2007).	  
26.	   Corbett,	  K.D.	  &	  Berger,	  J.M.	  Structure,	  molecular	  mechanisms,	  and	  evolutionary	  relationships	  in	  
DNA	  topoisomerases.	  Annual	  review	  of	  biophysics	  and	  biomolecular	  structure	  33,	  95-­‐118	  (2004).	  
27.	   Tse,	  Y.C.,	  Kirkegaard,	  K.	  &	  Wang,	  J.C.	  Covalent	  bonds	  between	  protein	  and	  DNA.	  Formation	  of	  
phosphotyrosine	  linkage	  between	  certain	  DNA	  topoisomerases	  and	  DNA.	  The	  Journal	  of	  
biological	  chemistry	  255,	  5560-­‐5	  (1980).	  
28.	   Hoadley,	  K.A.	  et	  al.	  Structure	  and	  cellular	  roles	  of	  the	  RMI	  core	  complex	  from	  the	  bloom	  
syndrome	  dissolvasome.	  Structure	  18,	  1149-­‐58	  (2010).	  
29.	   Wang,	  F.	  et	  al.	  Crystal	  structures	  of	  RMI1	  and	  RMI2,	  two	  OB-­‐fold	  regulatory	  subunits	  of	  the	  BLM	  
complex.	  Structure	  18,	  1159-­‐70	  (2010).	  
30.	   Hoadley,	  K.A.	  et	  al.	  Defining	  the	  molecular	  interface	  that	  connects	  the	  Fanconi	  anemia	  protein	  
FANCM	  to	  the	  Bloom	  syndrome	  dissolvasome.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  
of	  the	  United	  States	  of	  America	  109,	  4437-­‐42	  (2012).	  
31.	   Deans,	  A.J.	  &	  West,	  S.C.	  FANCM	  connects	  the	  genome	  instability	  disorders	  Bloom's	  Syndrome	  
and	  Fanconi	  Anemia.	  Molecular	  cell	  36,	  943-­‐53	  (2009).	  
32.	   Lima,	  C.D.,	  Wang,	  J.C.	  &	  Mondragon,	  A.	  Three-­‐dimensional	  structure	  of	  the	  67K	  N-­‐terminal	  
fragment	  of	  E.	  coli	  DNA	  topoisomerase	  I.	  Nature	  367,	  138-­‐46	  (1994).	  
33.	   Hansen,	  G.,	  Harrenga,	  A.,	  Wieland,	  B.,	  Schomburg,	  D.	  &	  Reinemer,	  P.	  Crystal	  structure	  of	  full	  
length	  topoisomerase	  I	  from	  Thermotoga	  maritima.	  Journal	  of	  molecular	  biology	  358,	  1328-­‐40	  
(2006).	  
34.	   Mondragon,	  A.	  &	  DiGate,	  R.	  The	  structure	  of	  Escherichia	  coli	  DNA	  topoisomerase	  III.	  Structure	  7,	  
1373-­‐83	  (1999).	  
35.	   Aravind,	  L.,	  Leipe,	  D.D.	  &	  Koonin,	  E.V.	  Toprim-­‐-­‐a	  conserved	  catalytic	  domain	  in	  type	  IA	  and	  II	  
topoisomerases,	  DnaG-­‐type	  primases,	  OLD	  family	  nucleases	  and	  RecR	  proteins.	  Nucleic	  acids	  
research	  26,	  4205-­‐13	  (1998).	  
36.	   Duguet,	  M.,	  Serre,	  M.C.	  &	  Bouthier	  de	  La	  Tour,	  C.	  A	  universal	  type	  IA	  topoisomerase	  fold.	  
Journal	  of	  molecular	  biology	  359,	  805-­‐12	  (2006).	  
37.	   Schultz,	  S.C.,	  Shields,	  G.C.	  &	  Steitz,	  T.A.	  Crystal	  structure	  of	  a	  CAP-­‐DNA	  complex:	  the	  DNA	  is	  bent	  
by	  90	  degrees.	  Science	  253,	  1001-­‐7	  (1991).	  
38.	   Brennan,	  R.G.	  &	  Matthews,	  B.W.	  The	  helix-­‐turn-­‐helix	  DNA	  binding	  motif.	  The	  Journal	  of	  
biological	  chemistry	  264,	  1903-­‐6	  (1989).	  
39.	   Flynn,	  R.L.	  &	  Zou,	  L.	  Oligonucleotide/oligosaccharide-­‐binding	  fold	  proteins:	  a	  growing	  family	  of	  
genome	  guardians.	  Critical	  reviews	  in	  biochemistry	  and	  molecular	  biology	  45,	  266-­‐75	  (2010).	  
40.	   Goulaouic,	  H.	  et	  al.	  Purification	  and	  characterization	  of	  human	  DNA	  topoisomerase	  IIIalpha.	  
Nucleic	  acids	  research	  27,	  2443-­‐50	  (1999).	  
41.	   Changela,	  A.,	  DiGate,	  R.J.	  &	  Mondragon,	  A.	  Crystal	  structure	  of	  a	  complex	  of	  a	  type	  IA	  DNA	  
topoisomerase	  with	  a	  single-­‐stranded	  DNA	  molecule.	  Nature	  411,	  1077-­‐81	  (2001).	  
	   	   25	  
42.	   Changela,	  A.,	  DiGate,	  R.J.	  &	  Mondragon,	  A.	  Structural	  studies	  of	  E.	  coli	  topoisomerase	  III-­‐DNA	  
complexes	  reveal	  a	  novel	  type	  IA	  topoisomerase-­‐DNA	  conformational	  intermediate.	  Journal	  of	  
molecular	  biology	  368,	  105-­‐18	  (2007).	  
43.	   Schmidt,	  B.H.,	  Burgin,	  A.B.,	  Deweese,	  J.E.,	  Osheroff,	  N.	  &	  Berger,	  J.M.	  A	  novel	  and	  unified	  two-­‐
metal	  mechanism	  for	  DNA	  cleavage	  by	  type	  II	  and	  IA	  topoisomerases.	  Nature	  465,	  641-­‐4	  (2010).	  
44.	   Li,	  Z.,	  Mondragon,	  A.,	  Hiasa,	  H.,	  Marians,	  K.J.	  &	  DiGate,	  R.J.	  Identification	  of	  a	  unique	  domain	  
essential	  for	  Escherichia	  coli	  DNA	  topoisomerase	  III-­‐catalysed	  decatenation	  of	  replication	  
intermediates.	  Molecular	  microbiology	  35,	  888-­‐95	  (2000).	  
45.	   Beranek,	  D.T.	  Distribution	  of	  methyl	  and	  ethyl	  adducts	  following	  alkylation	  with	  monofunctional	  
alkylating	  agents.	  Mutation	  research	  231,	  11-­‐30	  (1990).	  
46.	   Krogh,	  B.O.	  &	  Symington,	  L.S.	  Recombination	  proteins	  in	  yeast.	  Annual	  review	  of	  genetics	  38,	  
233-­‐71	  (2004).	  
47.	   Feinberg,	  H.,	  Lima,	  C.D.	  &	  Mondragon,	  A.	  Conformational	  changes	  in	  E.	  coli	  DNA	  topoisomerase	  
I.	  Nature	  structural	  biology	  6,	  918-­‐22	  (1999).	  
48.	   Xiong,	  B.	  et	  al.	  The	  type	  IA	  topoisomerase	  catalytic	  cycle:	  A	  normal	  mode	  analysis	  and	  molecular	  
dynamics	  simulation.	  Proteins	  71,	  1984-­‐94	  (2008).	  
49.	   Li,	  Z.,	  Mondragon,	  A.	  &	  DiGate,	  R.J.	  The	  mechanism	  of	  type	  IA	  topoisomerase-­‐mediated	  DNA	  
topological	  transformations.	  Molecular	  cell	  7,	  301-­‐7	  (2001).	  
50.	   Kabsch,	  W.	  Automatic	  Processing	  of	  Rotation	  Diffraction	  Data	  from	  Crystals	  of	  Initially	  Unknown	  
Symmetry	  and	  Cell	  Constants.	  Journal	  of	  Applied	  Crystallography	  26,	  795-­‐800	  (1993).	  
51.	   Mccoy,	  A.J.	  et	  al.	  Phaser	  crystallographic	  software.	  Journal	  of	  Applied	  Crystallography	  40,	  658-­‐
674	  (2007).	  
52.	   Stein,	  N.	  CHAINSAW:	  a	  program	  for	  mutating	  pdb	  files	  used	  as	  templates	  in	  molecular	  
replacement.	  Journal	  of	  Applied	  Crystallography	  41,	  641-­‐643	  (2008).	  
53.	   Adams,	  P.D.	  et	  al.	  PHENIX:	  a	  comprehensive	  Python-­‐based	  system	  for	  macromolecular	  structure	  
solution.	  Acta	  Crystallographica	  Section	  D-­‐Biological	  Crystallography	  66,	  213-­‐221	  (2010).	  
54.	   Murshudov,	  G.N.,	  Vagin,	  A.A.	  &	  Dodson,	  E.J.	  Refinement	  of	  macromolecular	  structures	  by	  the	  
maximum-­‐likelihood	  method.	  Acta	  Crystallographica	  Section	  D-­‐Biological	  Crystallography	  53,	  
240-­‐255	  (1997).	  




Figure	  1.	  Overall	  architecture	  and	  TopIIIα/RMI1	  binding	  interface	  
Fig	  1	  a)	  Domain	  organisation	  of	  the	  human	  TopIIIα	  /	  RMI1	  complex.	  The	  dashed	  region	  are	  not	  included	   in	   the	   final	  model	   (see	  methods)	   b)	  Overall	   architecture	   of	   the	   crystallized	   complexe	  (pdb	  from	  Ca).	  Toprim	  domain	  (I)	  is	  in	  cyan;	  the	  gate	  domain	  (II)	  with	  the	  two	  topo	  fold	  domain	  in	  green;	  catalytic	  5Y-­‐CAP	  domain	  (III)	  in	  blue,	  and	  non	  catalytic	  CAP	  domain	  (IV)	  in	  grey.	  RMI1	  is	  in	  red.	  The	  ion	  binding	  site	  in	  the	  catalytic	  site	  is	  represented	  as	  a	  red	  sphere.	  The	  four	  smaller	  inserts	  show	  the	  spread	  interaction	  network	  between	  RMI1	  and	  TopIIIα.	  c)	  Hydrophobic	  zipper	  between	   residues	   from	   OB	   domain	   (belonging	   to	   β1,	   β2,	   β3	   and	   β5A	   strands	   as	   well	   as	   to	  insertion,	  β3-­‐β4,	  and	  β4-­‐β5A	  loops)	  of	  RMI1	  and	  residues	  belonging	  to	  α12	  and	  β10-­‐α12	  loop	  of	  TopIIIα.	   d)	   Hydrogen	   bonding	   network	   between	   residues	   of	   α3-­‐β1,	   β4-­‐β5A	   and	   β3-­‐β4	   RMI1	  loops	  and	  residues	  of	  TopIII	  α	  α12	  and	  β10-­‐α12	  loop.	  TopIIIα	  E305	  and	  RMI1	  R176	  create	  a	  salt	  bridge.	  e)	  Hydrophobic	  patch	  clamping	  the	  bottom	  of	  the	  RMI1	  insertion	  loop	  to	  the	  TopIIIα	  α19	  helix.	   An	   additional	   zone	   of	   hydrophobic	   contacts	   is	   shown	  between	  TopIIIα	  α11-­‐β9	   loop	   and	  	  the	  beginning	  of	  RMI1	  αI	  as	  well	  as	  I211	  from	  RMI1	  αC	  helix.	  P98	  creates	  a	  stacking	  interaction	  with	  TopIIIα	  F94	  as	  well	  as	  Y100	  with	  TopIIIα	  F262.	  In	  this	  region	  I211	  from	  αC	  interacts	  with	  V263	  maintaining	   the	  RMI1	   C	   terminus	   close	   to	   the	   beginning	   of	  αI.	   At	   the	   top	   of	   the	   TopIIIα	  Domain	   IV	   on	   α19,	   A118	   and	   V116	   interact	   hydrophobically	   with	   A521,	   A525	   and	   A526.	   f)	  Hydrogen	   bonding	   network	   in	   the	   same	   area	   described	   than	   in	   e	   panel.	   A	   ionic	   interaction	  between	   RMI1	   E119	   and	   TopIIIα	   R338	   contributes	   to	   hold	   the	   RMI1	   insertion	   loop	   in	   this	  position.	  RMI1	  Q113	  is	  at	  the	  center	  of	  a	  hydrogen	  bonding	  network	  involving	  the	  oxygen	  of	  the	  carboxylic	   group	  of	   TopIIIα	  α11	  E254	   as	  well	   as	   the	   imidazol	   group	  of	  H530	   and	   the	  ε-­‐amino	  group	  of	  K529.	  	  	  	  	  
	   	  
Figure	  2	  Topoisomerase	  III	  α 	  catalytic	  site.	  
	  
	  	  
Fig2.	   Catalytic	   site	   of	   human	   TopIIIα .	  a)	   catalytic	   site	   residues	   and	  Mg2+	   binding	   site.	   2fo-­‐fc	  map	   is	   contoured	   at	   1.5σ.	  Mg2+	   is	   represented	   as	   a	   blue	   sphere	   and	  water	  molecules	   from	   the	  coordination	  shell	  as	  red	  spheres.	  Polar	  contacts	  are	  represented	  as	  dashed	  black	  lines.	  E41	  is	  the	  sole	   residue	   directly	   contacting	   the	   Mg2+	   ion	   while	   Y362,	   D150	   and	   E352	   bridge	   the	   water	  molecules.	   b)	   Structural	   alignement	   of	   the	   different	   catalytic	   sites	   from	   crystallised	  topoisomerases	  from	  the	  1A	  family.	  Cyan	  is	  E.	  coli	  Top3	  in	  apo	  state	  (pdb	  1D6M),	  magenta	  is	  E.	  
coli	   Top1A	   in	   apo	   state	   (pdb	   1ECL),	   grey	   is	   Top1A	   from	  Thermotoga	  maritima	   (pdb	   2GAI),	   in	  green	  the	  human	  TopIIIα	  described	  in	  this	  paper	  (pdb	  with	  Mg2+).	  
	   	  




Fig3.	  a)	  Final	  model	  of	  the	  RMI1	  decatenation	  loop.	  2fo-­‐fc	  map	  is	  contoured	  at	  1σ.	  b)	  Comparison	  between	  E.	  coli	  Top3	  (shaded	  grey)	  and	  human	  TopIIIα	  (green).	  RMI1	  (shaded	  red)	  inserts	  motifs	  where	   E.	   coli	  Top3	   diverges	   from	   human	   TopIIIα.	   c)	   Sequence	   alignements	   between	   different	  yeast	  strains	  and	  the	  human	  RMI1	  protein	  at	  the	  bottom	  of	  the	  alignement.	  The	  shaded	  region	  on	  the	  S.	  cerevisiae	  sequence	  is	  the	  region	  which	  has	  been	  randomized	  in	  the	  rlRmi1	  construct	  (see	  Methods).	  	  	   	  
Figure	  4.	  The	  yeast	  RMI1	  decatenation	  loop	  stabilizes	  the	  Top3	  open	  form	  and	  
stimulates	  dissolution	  of	  dHJ	  
Fig	  4	  a)	  Relaxation	  assay	  comparing	  yeast	  Rmi1	  wild	  type	  and	  rlRmi1.	  Lane	  1	  is	  the	  substrate	  (PUC19)	  alone;	  Lane	  2	  is	  the	  relaxation	  activity	  of	  yeast	  Top3;	  Lanes	  3-­‐8,	  increasing	  concentrations	  of	  wtRmi1	  and	  Lanes	  8	  to	  14	  are	  rlRmi1	  titration.	  The	  same	  samples	  are	  run	  on	  1%	  agarose	  gels	  containing	  EtBr	  or	  not	  to	  discriminate	  linear	  DNA	  from	  nicked	  DNA	  (see	  methods).	  b)	  The	  graph	  represents	  the	  densitometric	  analysis	  of	  the	  nicked	  DNA	  band	  intensity	  for	  WT	  (grey)	  and	  rl	  (black)	  on	  the	  EtBr	  gel.	  c)	  Catenation	  of	  PUC19	  substrate	  by	  the	  in	  vitro	  reconstituted	  yeast	  bloom	  complex	  with	  wild	  type	  Rmi1	  (Lanes	  3	  to	  6)	  and	  rlRmi1	  (lanes	  7	  to	  10).	  The	  appearing	  catenated	  products	  are	  signalled	  with	  a	  black	  arrow.	  d)	  Digest	  of	  M13	  substrate	  with	  the	  different	  complexes	  used	  in	  relaxation	  and	  catenation	  assays.	  Y356F	  Top3	  mutant	  is	  catalytically	  inactive.	  e)	  Dissolution	  assay	  on	  the	  yeast	  proteins.	  The	  dissolution	  in	  presence	  of	  wtRmi1	  is	  strongly	  stimulated	  as	  shown	  by	  the	  increased	  amount	  of	  dissolution	  product.	  In	  the	  presence	  of	  rlRmi1,	  the	  level	  of	  dissolution	  returns	  at	  the	  basal	  activity	  seen	  in	  the	  absence	  of	  Rmi1.	  f)	  MMS	  sensitivity	  drop	  assay	  on	  rlRmi1	  yeast	  strain.	  The	  different	  haploid	  strains	  are	  plated	  in	  1:10	  serial	  dilutions	  on	  YPAD	  ±	  MMS	  0.012%.	  The	  rlRmi1	  and	  ΔRmi1	  show	  the	  same	  sensitivity	  to	  MMS,	  one	  order	  of	  magnitude	  higher	  than	  for	  the	  WT.	  
Figure	  5.	  	  Proposed	  decatenation	  model	  by	  Top3α -­‐RMI1	  complex	  
	  
Fig5.	   Role	   of	   RMI1	   decatenation	   loop	   in	   hemicatenane	   dissolution.	  To	  decatenate	  and,	  by	  extension,	   to	   dissolve	   dHJ	   intermediates,	   TopIIIα	   (in	   green)	   has	   first	   to	   load	   on	   hemicatenane	  substrate	  and	  nick	  the	  C-­‐strand	  (in	  black)	  (step	  2)	  bound	  in	  the	  catalytic	  site	  in	  order	  to	  create	  a	  gap	  through	  which	  the	  T-­‐strand	  (in	  grey)	  can	  be	  passed.	  The	  strand	  passage	  step	  (step	  3)	  can	  be	  then	  achieved	  following	  the	  opening	  of	   the	  TopIIIα	  gate.	  RMI1	  (in	  red)	  wild	  type	  stabilizes	  this	  step	  by	  favouring	  the	  TopIIIα	  open	  form	  while	  the	  rlRMI1	  construct	  will	  displace	  the	  equilibrium	  towards	  the	  closed	  form	  disfavouring	  the	  strand	  passage	  in	  trans.	  Once	  the	  T-­‐strand	  is	  inside	  the	  gate,	   the	   latter	   re-­‐closes	   to	   religate	   the	   C-­‐strand,	   trapping	   the	   T-­‐strand	   (step	   4).	   The	   steric	  crowding	  of	  the	  gate	  by	  the	  RMI1	  decatenation	  loop	  exclusively	  allows	  ssDNA	  to	  be	  catalysed	  by	  the	  complex	  and	  to	  be	  passed	  through	  the	  gate.	  Step	  5	  corresponds	  to	  the	  final	  release	  of	  the	  C	  and	  T	   strands	  by	   re-­‐opening	  of	   the	  gate	   ending	   in	  disentanglement	  of	   the	   two	  DNA	  molecules.	  The	   complex	   finally	   comes	   back	   under	   its	   unbound	   state	   where	   it	   will	   be	   able	   to	   decatenate	  another	  substrate.	  
	  
	  
	  
